DIABIO — Diagonal Bio AB Income Statement
0.000.00%
Last trade - 00:00- SEK14.02m
- SEK12.29m
- SEK0.02m
Annual income statement for Diagonal Bio AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|
| Period Length: | 41 W | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS |
| Standards: | — | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 0.02 | 0.407 | 0.203 | 0.023 |
| Cost of Revenue | ||||
| Gross Profit | -6.38 | -15.5 | -11.5 | -9.57 |
| Selling / General / Administrative Expenses | ||||
| Depreciation and Amortization | ||||
| Other Operating Expenses | ||||
| Total Operating Expenses | 0.604 | 12.1 | 15.4 | 11.6 |
| Operating Profit | -0.583 | -11.7 | -15.2 | -11.6 |
| Total Net Non Operating Interest Income / Expense | ||||
| Net Income Before Taxes | -0.583 | -11.7 | -16.2 | -11.7 |
| Net Income After Taxes | -0.583 | -11.7 | -16.2 | -11.7 |
| Net Income Before Extraordinary Items | ||||
| Net Income | -0.583 | -11.7 | -16.2 | -11.7 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Diluted Net Income | -0.583 | -11.7 | -16.2 | -11.7 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | -0.015 | -0.296 | -0.67 | -0.126 |
| Dividends per Share |